Immunogenicity, Safety and Tolerability, of Chiron Meningococcal C Conjugate Vaccine Administered to Healthy Premature and Non Premature Children of 3 Months of Age
PHASE3CompletedINTERVENTIONAL
Enrollment
150
Participants
Timeline
Start Date
September 30, 2004
Conditions
Prevention of Meningococcal Infection
Interventions
BIOLOGICAL
Meningococcal C Conjugate Vaccine
Trial Locations (1)
20122
Istituto di Pediatria, Università degli Studi di Milano, Milan